Showing 2441-2450 of 3137 results for "".
- New Consensus Algorithm Guides Skincare Use With Energy-Based Acne Treatmentshttps://modernaesthetics.com/news/new-consensus-algorithm-guides-skincare-use-with-energy-based-acne-treatments/2485595/A new consensus-based study published in Journal of Drugs in Dermatology outlines a practical, stepwise algorithm for integrating skincare with energy-based devices (EBDs) in the management of acne and acne sequelae. Titled “Practical Algorithm for Acne Treatment Integrating Skincare
- New JDD Study Explores Aesthetic Motivations of African American Womenhttps://modernaesthetics.com/news/new-jdd-study-explores-aesthetic-motivations-of-african-american-women/2485593/A new survey-based study published in Journal of Drugs in Dermatology examines the cosmetic concerns, motivations, and skincare behaviors that shape the aesthetic journey of African American (AA) women, highlighting hair loss and hyperpigmentation as leading priorities in this population
- IMCAS 2026: Galderma Survey Sheds Light on Menopause and Skin Healthhttps://modernaesthetics.com/news/imcas-2026-galderma-survey-sheds-light-on-menopause-and-skin-health/2485587/Galderma presented findings from a large global survey examining the dermatologic impact of menopause at the International Master Course on Aging Science (IMCAS) 2026 World Congress, held January 29–31 in Paris, France. The survey notes persistent gaps in awareness and education around menopause-
- Octane Aesthetics Tech Forum: Clinical Strategies for Managing Rapid Weight Loss in Aestheticshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-clinical-strategies-for-managing-rapid-weight-loss-in-aesthetics/2485537/The widespread use of GLP-1 receptor agonists (GLP-1 RAs) is ushering in a new era of aesthetic medicine that demands a more nuanced approach to skin aging, hormonal health, and treatment planning. That was the consensus from a panel of aesthetic surgeons and regenerative medicine experts
- Octane Aesthetics Tech Forum: 3 Big Trends from GuidePoint Qsight’s 2025 Market Analysishttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-3-big-trends-from-guidepoint-qsights-2025-market-analysis/2485514/At the 2026 Octane Aesthetic Tech Forum, Erik Haines, Managing Director of Guidepoint Qsight, presented a data-rich snapshot of the state of the medical aesthetics industry. Drawing from over $17 billion in transactional data across 45,000 aesthetic practices and millions of patient records, Hain
- Injectable Skin Boosters Market Set to Exceed $3.2 Billion by 2032, Driven by HA-Based Rejuvenation Trendshttps://modernaesthetics.com/news/injectable-skin-boosters-market-set-to-exceed-32-billion-by-2032-driven-by-ha-based-rejuvenation-trends/2485495/The global market for injectable skin boosters is projected to more than double over the next decade, climbing from $1,492.17 million in 2025 to an estimated $3,263.80 million by 2032, according to new data from MMR Statistics. This represents a compound annual gro
- New Study Supports Combined Approach for Facial Rejuvenationhttps://modernaesthetics.com/news/new-study-supports-combined-approach-for-facial-rejuvenation/2485450/New research in the Journal of Cosmetic Dermatology supported the use of combined radiofrequency microneedling (RFMN) and 1927 nm thulium (Tm) laser treatment versus RFMN monotherapy for lower face and neck rejuvenation in photoaged skin.
- Octane Aesthetics Tech Forum: GLP-1 Receptor Agonists Are Reshaping Consumer Behavior and Aesthetic Business Modelshttps://modernaesthetics.com/news/octane-aesthetics-tech-forum-glp-1-receptor-agonists-are-reshaping-consumer-behavior-and-aesthetic-business-models/2485431/The rise of GLP-1 receptor agonist (GLP-1RA) medications is doing more than transforming bodies; it is reshaping the very business of aesthetics. At the 2026 Octane Aesthetics Tech Forum, panelists described how GLP-1RAs are influencing patient behavior, redefining value propositions, and catalyz
- skinbetter science® Marks 10 Years of AlphaRet® Technology in Retinoid-AHA Skincarehttps://modernaesthetics.com/news/skinbetter-science-marks-10-years-of-alpharet-technology-in-retinoid-aha-skincare/2485358/skinbetter science® is marking the 10-year anniversary of its proprietary AlphaRet® technology, introduced in 2016 as one of the first topical skincare formulas to combine a retinoid with an alpha hydroxy acid (AHA). The combination, used in the flagship AlphaRet Overnight Cream, was designed to
- FDA Approves Once-Daily Oral Semaglutidehttps://modernaesthetics.com/news/fda-approves-once-daily-oral-semaglutide/2485258/The US Food and Drug Administration (FDA) has approved Novo Nordisk’s once-daily oral formulation of semaglutide, marketed as Wegovy® pill, marking the first oral GLP-1 receptor agonist approved for chronic weight management in the United States. The approval includes indications for adults with